The global market for Digital Breast Tomosynthesis was estimated at US$3.1 Billion in 2025 and is projected to reach US$7.1 Billion by 2032, growing at a CAGR of 12.8% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Technological advancements in DBT have significantly contributed to its widespread adoption and effectiveness. Modern DBT systems are equipped with advanced software algorithms that improve image quality and reduce radiation dose. The integration of artificial intelligence (AI) and machine learning into DBT systems further enhances diagnostic accuracy by assisting radiologists in detecting subtle abnormalities and reducing reading times. Additionally, continuous improvements in detector technology and image reconstruction techniques have made DBT a more reliable and efficient tool for breast cancer screening. The combination of these technological advancements ensures that DBT remains at the forefront of breast imaging, offering unparalleled diagnostic capabilities compared to conventional mammography.
The growth in the digital breast tomosynthesis market is driven by several factors. The rising prevalence of breast cancer globally has heightened the demand for more accurate and reliable screening methods, positioning DBT as a preferred choice. Technological innovations, such as AI integration and improved image processing, have expanded the capabilities of DBT systems, making them more effective and user-friendly. Increasing awareness among women about the importance of regular breast cancer screening and the advantages of DBT over traditional methods is also driving market adoption. Moreover, supportive government policies and reimbursement frameworks in many regions are facilitating access to DBT, encouraging healthcare facilities to invest in this advanced technology. Additionally, the growing focus on personalized medicine and patient-centric care is pushing for the adoption of DBT, which offers more detailed and individualized diagnostic information. Collectively, these factors are fueling the rapid expansion and development of the digital breast tomosynthesis market.
Global Digital Breast Tomosynthesis Market - Key Trends and Drivers Summarized
Digital Breast Tomosynthesis (DBT), also known as 3D mammography, is a revolutionary imaging technology that improves the accuracy of breast cancer detection and diagnosis. Unlike traditional two-dimensional mammography, DBT captures multiple images of the breast from different angles, creating a layered, three-dimensional reconstruction. This method enhances the radiologist's ability to identify and characterize breast lesions, reducing the likelihood of false positives and unnecessary biopsies. DBT is particularly beneficial for women with dense breast tissue, where traditional mammography might miss abnormalities. Since its approval by the FDA in 2011, DBT has been increasingly adopted in clinical practice, leading to better patient outcomes and more precise breast cancer screening protocols.Technological advancements in DBT have significantly contributed to its widespread adoption and effectiveness. Modern DBT systems are equipped with advanced software algorithms that improve image quality and reduce radiation dose. The integration of artificial intelligence (AI) and machine learning into DBT systems further enhances diagnostic accuracy by assisting radiologists in detecting subtle abnormalities and reducing reading times. Additionally, continuous improvements in detector technology and image reconstruction techniques have made DBT a more reliable and efficient tool for breast cancer screening. The combination of these technological advancements ensures that DBT remains at the forefront of breast imaging, offering unparalleled diagnostic capabilities compared to conventional mammography.
The growth in the digital breast tomosynthesis market is driven by several factors. The rising prevalence of breast cancer globally has heightened the demand for more accurate and reliable screening methods, positioning DBT as a preferred choice. Technological innovations, such as AI integration and improved image processing, have expanded the capabilities of DBT systems, making them more effective and user-friendly. Increasing awareness among women about the importance of regular breast cancer screening and the advantages of DBT over traditional methods is also driving market adoption. Moreover, supportive government policies and reimbursement frameworks in many regions are facilitating access to DBT, encouraging healthcare facilities to invest in this advanced technology. Additionally, the growing focus on personalized medicine and patient-centric care is pushing for the adoption of DBT, which offers more detailed and individualized diagnostic information. Collectively, these factors are fueling the rapid expansion and development of the digital breast tomosynthesis market.
Report Scope
The report analyzes the Digital Breast Tomosynthesis market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:- Segments: Product Type (2D / 3D Combination Mammography Systems, Standalone 3D Mammography Systems); End-Use (Hospitals End-Use, Diagnostic Centers End-Use, Other End-Uses).
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the 2D / 3D Combination Mammography Systems segment, which is expected to reach US$1.6 Billion by 2032 with a CAGR of 14.7%. The Standalone 3D Mammography Systems segment is also set to grow at 12.3% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $948.5 Million in 2025, and China, forecasted to grow at an impressive 17.5% CAGR to reach $1.8 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Digital Breast Tomosynthesis Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Digital Breast Tomosynthesis Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Digital Breast Tomosynthesis Market expected to evolve by 2032?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2032?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Allengers Medical Systems Ltd., Canon Medical Systems Corporation, FUJIFILM Healthcare Americas Corporation, GE HealthCare PLC, Hologic, Inc. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the companies featured in this Digital Breast Tomosynthesis market report include:
- Allengers Medical Systems Ltd.
- Canon Medical Systems Corporation
- FUJIFILM Healthcare Americas Corporation
- GE HealthCare PLC
- Hologic, Inc.
- I.M.S. (Internazionale Medico Scientifica) Srl
- LBN Medical
- Metaltronica SpA
- Planmed Oy
- Shanghai United Imaging Healthcare Co., LTD
- Siemens Healthcare GmbH
- Trivitron Healthcare
Domain Expert Insights
This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 43 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Allengers Medical Systems Ltd.
- Canon Medical Systems Corporation
- FUJIFILM Healthcare Americas Corporation
- GE HealthCare PLC
- Hologic, Inc.
- I.M.S. (Internazionale Medico Scientifica) Srl
- LBN Medical
- Metaltronica SpA
- Planmed Oy
- Shanghai United Imaging Healthcare Co., LTD
- Siemens Healthcare GmbH
- Trivitron Healthcare
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 279 |
| Published | June 2026 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 3.1 Billion |
| Forecasted Market Value ( USD | $ 7.1 Billion |
| Compound Annual Growth Rate | 12.8% |
| Regions Covered | Global |
